SCOPUS 정보 검색 플랫폼

The Lancet Oncology

Volumn 14, Issue 12, 2013, Pages 1156-1157

Need for change in implementation of paediatric regulation

(3) Vassal, Gilles a Blanc, Patricia b Pearson, Andy c

a INSTITUT GUSTAVE ROUSSY (France)

b Imagine for Margo (France)

c INSTITUTE OF CANCER RESEARCH (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ORPHAN DRUG;

CANCER RESEARCH; CHILD HEALTH CARE; CHILDHOOD CANCER; DRUG APPROVAL; DRUG INDUSTRY; DRUG LEGISLATION; DRUG MARKETING; HEALTH CARE ORGANIZATION; HEALTH CARE PLANNING; HUMAN; LETTER; PRIORITY JOURNAL;

ADOLESCENT; AGE FACTORS; ANTINEOPLASTIC AGENTS; CHILD; EUROPE; GUIDELINE ADHERENCE; HUMANS; MEDICAL ONCOLOGY; ORPHAN DRUG PRODUCTION; PEDIATRICS; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; RISK FACTORS;

EID: 84886647702 PISSN: 14702045 EISSN: 14745488 Source Type: Journal
DOI: 10.1016/S1470-2045(13)70467-4 Document Type: Letter

Times cited : (15)

References (6)

1
- 0003495136
- Commission to the European Parliament and Council, (accessed Oct 9, 2013).
- Better Medicines for Children - From Concept to Reality. General Report on experience acquired as a result of the application of Regulation (EC) No 1901/2006 on medicinal products for paediatric use Commission to the European Parliament and Council, (accessed Oct 9, 2013). http://ec.europa.eu/health/files/paediatrics/2013_com443/paediatric_report-com(2013)443_en.pdf.
- Better Medicines for Children - From Concept to Reality. General Report on experience acquired as a result of the application of Regulation (EC) No 1901/2006 on medicinal products for paediatric use

2
- 84886681759
- European Medical Agency, (accessed Oct 9, 2013).
- 5-year Report to the European Commission. General report on the experience acquired as a result of the application of the Paediatric Regulation European Medical Agency, (accessed Oct 9, 2013). http://ec.europa.eu/health/files/paediatrics/2012-09_pediatric_report-annex1-2_en.pdf.
- 5-year Report to the European Commission. General report on the experience acquired as a result of the application of the Paediatric Regulation

3
- 84886677902
- Commission to the European Parliament and Council, (accessed Oct 9, 2013).
- General Report on experience acquired as a result of the application of the Paediatric Regulation (Article 50(2) of regulation (EC) NO1901/2006: summary of the replies to the public consultation Commission to the European Parliament and Council, (accessed Oct 9, 2013). http://ec.europa.eu/health/files/paediatrics/2013_pc_paediatrics/2013_paediatric_report_summary.pdf.
- General Report on experience acquired as a result of the application of the Paediatric Regulation (Article 50(2) of regulation (EC) NO1901/2006: summary of the replies to the public consultation

4
- 84875246025
- New drugs for children and adolescents with cancer: the need for novel development pathways
- Vassal G, Zwaan CM, Ashley D, et al. New drugs for children and adolescents with cancer: the need for novel development pathways. Lancet Oncol 2013, 14:e117-e124.
- (2013) Lancet Oncol , vol.14
- Vassal, G.¹ Zwaan, C.M.² Ashley, D.³

5
- 84875127324
- Is the European pediatric medicine regulation working for children and adolescents with cancer?
- Vassal G, Geoerger B, Morland B Is the European pediatric medicine regulation working for children and adolescents with cancer?. Clin Cancer Res 2013, 19:1315-1325.
- (2013) Clin Cancer Res , vol.19 , pp. 1315-1325
- Vassal, G.¹ Geoerger, B.² Morland, B.³

6
- 84868585646
- Medicines for pediatric oncology: can we overcome the failure to deliver?
- Saint-Raymond A, Herold R Medicines for pediatric oncology: can we overcome the failure to deliver?. Exp Rev Clin Pharmacol 2012, 5:493-495.
- (2012) Exp Rev Clin Pharmacol , vol.5 , pp. 493-495
- Saint-Raymond, A.¹ Herold, R.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.